Position in TEVA
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$2,926,248
-$623,483 QoQ
Shares Held
97,153
-14.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parrish Capital LLC holds $3,275,426 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (89.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
97,153 | $2,926,248 | |
| 2 | PRGO |
PERRIGO Co plc
|
32,512 | $349,178 |
All Filings in TEVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,926,248 | 97,153 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,549,731 | 113,737 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||